跳至主要内容
临床试验/CTRI/2023/08/056393
CTRI/2023/08/056393尚未招募3 期

Effectiveness of Individualised Homoeopathic Medicines in the Treatment of Subclinical Hypothyroidism: An open-label observational study

Dr Niharika Shaw1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2023年8月15日最近更新:

试验速览

阶段
3 期
状态
尚未招募
发起方
入组人数
30
试验地点
1
主要终点
Following preliminary screening,outcome data will be obtained based on inclusion and exclusion criteria, as mentioned above, will be followed.

研究概览

简要总结

Subclinicalhypothyroidism (SCH), also known as compensated hypothyroidism or mild hypothyroidism,a commonly found clinical entity is defined biochemically as a raised serumconcentration of thyroid stimulating hormone (TSH) with serum free thyroxine(FT4) in normal range.

SCH commonly affects6-17% of the Indian population. The population prevalence of SCH isaround 12-18%, diagnosis being more common in women and elderly population andhigher in whites than in black population.

Various studies and case reports have shown the efficacy of IndividualisedHomoepathic Medicines in the treatment of Subclinical hypothyroidism improvingboth quality of life of patient and standard of treatment of Subclinicalhypothyroidism. Homoeopathy treats the patient as a whole rather than just thedisease entity. Therefore, the aim of the study is to assess the effectivenessof Individualised Homoepathic Medicines in the treatment of Subclinicalhypothyroidism.

研究设计

研究类型
Interventional
分配方式
Not Applicable
盲法
Not Applicable

入排标准

年龄范围
18.00 Year(s) 至 65.00 Year(s)(—)
性别
All

入选标准

  • TSH 4-10mIU/ml
  • T3- Within normal range
  • T4- Within nkrmal range.

排除标准

  • TSH >10mIU/ml
  • Patient with any other major co-morbidity
  • Pregnant female
  • Patient addicted to some abuse
  • Patient taking other mode of treatment treatment.

结局指标

主要结局

Following preliminary screening,outcome data will be obtained based on inclusion and exclusion criteria, as mentioned above, will be followed.

时间窗: Every patient will be assessed periodically to follow-up the reaction of the remedy through ThyTSQ and Serum Thyroid profile test every 3 monthly. The usual follow up will be done at an interval of 4 weeks and will be recorded.

Each case will be studied properly through analysis and evaluation of each and every symptom then accordingly qualitative picture will be constructed on the basis of totality of symptom to prescribe simillimum.

时间窗: Every patient will be assessed periodically to follow-up the reaction of the remedy through ThyTSQ and Serum Thyroid profile test every 3 monthly. The usual follow up will be done at an interval of 4 weeks and will be recorded.

次要结局

  • •To assess the standard of treatment in Subclinical hypothyroidism patients with Individualised Homoeopathic Medicines by using Thyroid Treatment Satisfaction Questionnaire (Thy-TSQ).(6 months)

研究者

发起方
Dr Niharika Shaw
申办方类型
Other [self]

研究点 (1)

Loading locations...

相似试验